Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
ETFs with ABBV as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|8.26%||First Trust IPOX-100 Index Fund (FPX)||+3.97 (7.79%)|
|4.14%||Market Vectors Pharmaceutical ETF (PPH)||+8.14 (12.55%)|
|3.71%||Guggenheim Spin-Off ETF (CSD)||+3.26 (7.20%)|
|2.37%||SPDR S&P Pharmaceuticals ETF (XPH)||+15.10 (14.01%)|
|1.8%||SPDR MFS Systematic Value Equity ETF (SYV)||+3.33 (6.05%)|
Company Description (as filed with the SEC)
AbbVie(1) was incorporated in Delaware on April 10, 2012. On January 1, 2013, AbbVie became an independent company as a result of the distribution by Abbott Laboratories (Abbott) of 100 percent of the outstanding common stock of AbbVie to Abbott's shareholders. AbbVie's common stock began trading "regular-way" under the ticker symbol "ABBV" on the New York Stock Exchange on January 2, 2013. Overview AbbVie is a global, research-based biopharmaceutical company. AbbVie develops and markets advanced therapies that address some of the world's most complex and serious diseases. AbbVie's products are focused on treating conditions such as chronic autoimmune diseases, including rheumatoid arthritis, psoriasis, and Crohn's disease; hepatitis C (HCV); human immunodeficiency virus (HIV); endometriosis; thyroid disease; Parkinson's disease; complications associated with chronic kidney disease and cystic fibrosis; and other health conditions such as low testosterone. ... More ...
Where does ABBV fit in the risk graph?
|Annual EPS Est:||$3.32|
|Quarterly EPS Est:||1.07|